29263-11-4 Usage
General Description
2,4,6-tris(propan-2-yloxy)-1,3,5-triazine, also known as Cyanuric acid tris(2-propanol), is a chemical compound consisting of a triazine ring with three propan-2-yloxy substituents. It is commonly used as a cross-linking agent in the production of polymers, particularly in the manufacturing of resins and coatings. 2,4,6-tris(propan-2-yloxy)-1,3,5-triazine is also utilized as a stabilizer in the formulation of adhesives, plastics, and rubber products to improve their durability and resistance to heat and chemicals. Additionally, 2,4,6-tris(propan-2-yloxy)-1,3,5-triazine is employed as an intermediate in the synthesis of various organic compounds and pharmaceuticals. Despite its usefulness, this chemical should be handled with care due to its potential health hazards and environmental impacts.
Check Digit Verification of cas no
The CAS Registry Mumber 29263-11-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,2,6 and 3 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 29263-11:
(7*2)+(6*9)+(5*2)+(4*6)+(3*3)+(2*1)+(1*1)=114
114 % 10 = 4
So 29263-11-4 is a valid CAS Registry Number.
29263-11-4Relevant articles and documents
Synthesis and antiviral evaluation of some C3-symmetrical trialkoxy-substituted 1,3,5-triazines and their molecular geometry
Mibu, Nobuko,Yokomizo, Kazumi,Aki, Hatsumi,Ota, Norimasa,Fujii, Hiroyuki,Yuzuriha, Ai,Saneyoshi, Shiori,Tanaka, Aoi,Koga, Airi,Zhou, Jianrong,Miyata, Takeshi,Sumoto, Kunihiro
, p. 935 - 944 (2016/02/03)
As one of our projects, we here report some new molecular modifications of 2,4,6-trichloro-1,3,5-triazine (TCTAZ: 1) to symmetrical 2,4,6-trialkoxy- or 2,4,6-triaryloxy-substituted 1,3,5-triazine (TAZ) molecules, as well as the results of anti-herpes simplex virus type 1 (anti-HSV-1) activity evaluation of synthesized 2,4,6-trisubstituted TAZ derivatives. Among the tested 2,4,6-trisubstituted TAZ derivatives, we reconfirmed that a C3-symmetrical TAZ derivative, 4e, shows the highest level of anti-HSV-1 activity with a good selectivity index. In this paper, we also report the results of the preparation of newly targeted TAZ derivatives and the structure-activity relationships (SARs) of these trialkoxy-substituted TAZ derivatives and related compounds. The sugar recognition properties of C3-symmetrical TAZ derivative 4e are also described.
